AGP Executive Report
Last update: 12 minutes agoRegulation Watch: Massachusetts Cannabis Control Commission says most THC potency label checks on flower products were within range, but noncompliant items will be flagged and stopped from further sales. Retail Expansion: NatureMed opened its third Kentucky medical cannabis dispensary in Murray, aiming to cut travel time for patients and offering flower, edibles, and vaporizers. Clinical & Safety: A CDC update attributes a sharp rise in ER visits for cannabis hyperemesis syndrome to a new dedicated diagnosis code (introduced Oct. 1, 2025), not necessarily a true outbreak. Medical Evidence: UK registry data reports sustained improvements for endometriosis patients using cannabis-based medicinal products, including reduced pain and lower opioid use. Policy & Access: Georgia medical cannabis enrollment jumped after lawmakers expanded the program in May, adding more qualifying conditions and allowing botanical cannabis and higher-THC products. Research Signals: A new study links cannabis use with fewer premature heartbeats on use days in regular users, suggesting a potential heart rhythm effect worth watching. Enforcement: Nigeria customs seized cannabis sativa worth about N2.09bn, while other drug actions in Malaysia highlighted large multi-drug seizures and asset forfeitures.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
